University of Miami Neurology Update and Stroke Intensive Review 2026

Description

+ Include: 49 videos Only NO PDFS

+ Information:

1. Overview

The 59th Annual Neurology Update and Stroke Intensive Review 2026 provides clinicians with a comprehensive review of the most recent developments in the diagnosis and management of neurologic disorders, including stroke, cognitive neurology/brain health, epilepsy, multiple sclerosis (MS), movement disorders, neuromuscular disorders, headache/migraine, neuro-oncology, sleep disorders and general neurology. Challenging diagnostic and therapeutic questions will be raised in each session around representative clinical vignettes, targeted reviews of the topic by the faculty and panel discussions. Exchange of information between faculty and attendees will take place during questions and answers sessions after each presentation as well as round table and panel discussions.

Course Date: Thursday, March 5, 2026, 8:00 AM – Saturday, March 7, 2026, 6:00 PM, Loews Coral Gables, Miami, FL

2. Learning Objectives

1. By evaluating a detailed semiology, physicians will be able to more clearly distinguish the underlying etiology of paroxysmal psychiatric or behavioral symptoms.
2. Assess and anticipate potential risks of misdiagnosis and delay in proper treatment implementation.
3. Expand understanding diagnosis, novel therapeutics and evolving pathophysiology.
4. Integrate novel therapies into individualized care plans to reduce disability.
5. Assess the nuances in the diagnostics and management of meningiomas.
6. Improve the understanding of neurologic complications of cancer treatment and drug delivery.
7. Differentiate cancer immunotherapy–related myopathies from other inflammatory and toxic myopathies.
8. Recognize clinical red flags for life-threatening overlap presentations (myositis, myocarditis, myasthenia gravis)
9. Improve diagnostic accuracy when distinguishing PD from atypical parkinsonism using practical algorithms and bedside red flags; reduce inappropriate testing; initiate earlier, condition-specific counseling and care plans.
10. Strengthen bedside recognition of movement phenomenology through case videos; apply structured diagnostic frameworks; initiate first-line management or referral when indicated.
11. Identify and appropriately utilize high-efficacy therapies early in the disease course, optimizing long-term outcomes and reducing relapse-related morbidity in patients with MS.
12. Improved awareness and early recognition of immune-related neurological adverse events will facilitate timely interventions, thereby reducing morbidity in affected patients.
13. Apply current diagnostic strategies to distinguish benign conditions such as migraine aura or visual snow from urgent ischemic causes of transient visual loss.
14. Define the 2023 revisions to the AAN brain death criteria.
15. By following the National Institute on Aging- Alzheimer Association criteria for Alzheimer’s disease, Mild cognitive impairment due to Alzheimer’s disease, and presymptomatic Alzheimer’s disease, clinicians will be able to accurately diagnose this disorder.
16. By following the McKeith criteria for Dementia with Lewy Bodies and Mild Cognitive Impairment due to DLB, clinicians will be better able to recognize and diagnose this disorder.
17. Understand the use and value of the different imaging modalities used in the diagnosing Cervical Spondylotic Myopathy.
18. Properly identifying those patients who are at risk for a spinal cord injury.
19. Describe factors believed to be contributory to cognitive difficulties and guidelines to address them.
20. Understand a variety of psychotherapeutic techniques that can promote a better quality of life and treatment outcomes for patients with neurological conditions.

3. Target Audience

Best for neurologists and stroke specialists who want updates on acute stroke management, neurodegenerative diseases, and novel therapeutics.

Specialties – Alzheimer’s/Cognitive Disorders, Epilepsy, General Neurology, Headache/Migraine, Movement Disorders, Multiple Sclerosis, Neurology, Neuromuscular Diseases, Neuro-Oncology, Neuropsychology, Neurosurgery, Sleep Medicine, Stroke

Professions – General Neurologist

4. Topics

1. S.No	Name	Runtime
   1	From Heart to Brain: Contemporary Cardiac Strategies in Embolic Stroke Prevention	35:15
   2	Panel Discussion: Challenging Cases in Stroke Management – Part I	23:49
   3	Intracerebral Hemorrhage Update on the Medical Management	33:58
   4	Surgical Approaches Intracerebral Hemorrhage	17:39
   5	Updates on Treatment of Subdural Hemorrhage	06:24
   6	Stroke in Young Adults: Pregnancy, and Postpartum Period	31:46
   7	Stroke in the Young: Management of Cervical Artery Dissection	15:34
   8	Stroke in the Young: Management of Cerebral Venous Sinus Thrombosis	28:15
   9	Acute Management of TIA and Mild Stroke 2026 Update	29:43
   10	The Role of Carotid Revascularization in Stroke Prevention	41:24
   11	Diagnosed With Epilepsy. Now What?	21:22
   12	Evidenced-Based Therapeutic and Lifestyle Interventions for Movement Disorders	17:24
   13	Specific Psychotherapeutic Considerations for Patients With Neurological Conditions	15:23
   14	Slowing Down the Aging Clock: Sleep and Other Lifestyle Interventions That Work	15:47
   15	Diagnostic Dilemmas and Challenging Differential Diagnoses: Can Artificial Intelligence (AI) Help?	12:25
   16	Visual Disturbances in Neurology: Clinical Spectrum and Pathophysiology Insights	20:33
   17	Cervical Spondylotic Myelopathy	25:00
   18	Brain Death: Current Definition and Controversies	18:52
   19	Introduction to Sports Neurology and a Multidisciplinary Approach With Neuropsychology in the Management of Traumatic Brain Injury	25:52
   20	What Is New in Thrombolysis Extended Time Window and Special Situations	30:44
   21	Pushing Boundaries in Mechanical Thrombectomy: Rescue Strategies and Practical Considerations	26:46
   22	Antithrombotic Therapy Across the Stroke Continuum	36:09
   23	Current and Pipeline Therapies for Multiple Sclerosis	12:44
   24	Current Long-Term Therapies for Neuromyelitis Optica Spectrum Disorder (NMOSD)	27:11
   25	Recognizing Neurological Complications of Checkpoint Inhibitor Therapy	34:27
   26	Understanding Autoimmune Encephalitis	17:25
   27	Improving the Diagnosis, Treatment, and Prevention of Alzheimers Disease	25:48
   28	Improving the Diagnosis and Treatment of Lewy Body Dementia	30:25
   29	Beyond Alzheimer’s Disease: Mixed Pathologies and the Hidden Role of Epilepsy	26:03
   30	Breakthroughs in PD Care Stem Cells FUS and Studies for MSA PSP	31:54
   31	Case Series Presentation – Applied Diagnosis	24:57
   32	Meningioma: Nuances in Diagnosis and Management 2026 Update	24:54
   33	Gliomas: Recent Advances and Future Directions	27:54
   34	Enhancing Drug Delivery Across the Blood-Brain Barrier	27:08
   35	Shifting Perspective and Biases in Brain Tumor Care	16:45
   36	Essential Tremor and/or Parkinson’s Disease: Separate, Together, the Same?	19:26
   37	Enhancing Outcomes in Parkinsonian Disorders Through an Interdisciplinary Approach	23:06
   38	What Is New in Headache Medicine	27:41
   39	Refractory Headache Disorders	21:24
   40	Interventional Procedures for Trigeminal Neuralgia	25:22
   41	Advances in Acute and Preventive Treatment of Migraine	19:03
   42	Differential Diagnosis: Ictal Psychiatric Symptoms Versus Primary Psychiatric Disorder	27:57
   43	Semiology Findings: Functional Events vs Epileptic Seizures	29:21
   44	Functional/Dissociative Seizures (FDS): Management and Driving Recommendations	28:13
   45	Management of Antiseizure Medications in Functional/Dissociative Seizures	21:04
   46	Recognition and Management of Neuromuscular Complications of Cancer Immunotherapy	24:40
   47	Qalsody (tofersen) in ALS: Clinical Outcomes and Practical Management	22:47
   48	Changing the Trajectory: Lessons Learned From Disease Modifying Therapies for Childhood Neuromuscular Disorders	25:52
   49	Diagnostic Approaches to Demyelinating Neuropathies	24:27